🚨Post-doc opportunity🚨

My good friend and collaborator Mina T. is looking for a post-doc to work on utilization, outcomes, safety, effectiveness, and costs of drugs in Ontario 🇨🇦

Mina is a fantastic mentor!

linkedin.com/jobs/view/3907…

Looking forward to #ISPOR2024 in a few days. Check out the research of #CePOR faculty and students in the sessions below.
I'm also happy to have coffee with any prospective PhD students interested in our PhD program (pharmacy.cuanschutz.edu/academics/phd-…) CU Pharmacy Brett McQueen

Excited to share our new paper in JAMA exploring the role of APIs in drug shortages (jamanetwork.com/journals/jama/…)! Appreciate the incredible mentorship of Mariana Socal and Gerard Anderson. This work sheds light on critical issues in healthcare supply chains. Johns Hopkins Medicine

So proud to have been a member of Dr. Liu's dissertation committee. She's doing great work on Medicare Advantage and health care pricing and I'm excited to see her excel in the years to come!

Congratulations to 2024 Diversity Scholarship recipient Maitreyi Sahu, University of Washington Dept. of Health Metrics Sciences.

Learn more about the Diversity Scholarship here: ashecon.org/2024-san-diego…

Sponsored by Dalio Philanthropies, Cedars-Sinai Academic Medicine, @CommonwealthFnd and Arnold Ventures

Nice to see that our paper on alternative value measures was selected as a top paper in Expert Review of Pharmacoeconomics & Outcomes Research. Link below! Brett McQueen Kelly Anderson Kavita Nair

Samsun Naher and I are organizing a session on prescription drugs for #APPAM2024 and are looking for 1-2 more abstracts. Please contact me if you are interested! Kelly Anderson

With huge thanks to Michael Darden and Daniel Polsky - Hopkins Carey School of Business and HBHI are hosting 2024 AHEW; October 25-26.

The event will be at the Hopkins Bloomberg Building - next to the national mall on Pennsylvania Ave.

send papers to [email protected]

PSA: I didn't see a reminder email for my DUA renewals and ResDAC confirms that CMS is no longer regularly sending- I caught mine in time but usually depend on the emails, FYI if you're in the same boat!

Teaching health economics related classes this semester? Consider using (and adding to) @ashecon repository of syllabi and other teaching materials ashecon.org/teaching-mater… Thanks to those who created it, great to have this resource.

I have an abstract focused on pharmacy closures for #APPAM2024 and looking for related abstracts to put together a panel. #HealthPolicy abstracts on prescription drugs or geographic access to care could fit well. Let me know if you have a potential abstract APPAM

Nnnnnnoooooooo

No one is safe, not even cancer patients 😫

CMSGov is really committed to shutting down secondary data analysis, it seems
Adam Sacarny Anirban Basu Kelly Anderson Stacie Dusetzina Kevin Rinz Coleman Drake Aaron Schwartz Michael L. Barnett Rachel Werner Pragya Kakani Peter B. Bach, MD

Hi #EconTwitter ! I’m helping organize a couple of sessions for this year’s SEA and APPAM. If anyone’s presenting a paper on public policies and substance use/health outcomes, please reach out! 😊

I am hiring a postdoc to work on health econ topics related to Neurofibromatosis type 1 (NF1), a genetic tumor predisposition syndrome. 🧬 Work with a collaborative team of outcomes researchers and clinicians at CHeRP & Harvard hospitals. Apply here: tuftshealthplan.wd5.myworkdayjobs.com/THP/job/Boston…

New paper The BMJ w/ Ravi Gupta, Fein and Newhouse. We compared prior authorization rules across Medicare Advantage plans.

Part B services and drugs (especially) face lots of PA, with lots of variation across plans.
bmj.com/content/384/bm…

📢 Exciting news! 🎉 Just published a paper in Health Affairs with Zach Brown, Sarah Miller, Edward Norton, & Andrew Ryan. 🏥 Our study, funded by Arnold Ventures, examines the impact of the Oregon state employee plan’s hospital payment cap on hospital prices.

New paper with Karen Shen out today Health Services Research

We find that the growth of Medicare Advantage has worsened nursing homes' finances.
onlinelibrary.wiley.com/doi/10.1111/14…

We've drafted a response to the recent CMS RFI on additional data collection to study the Medicare Advantage program. Want to sign on? Send me an email by Friday March 8th

docs.google.com/document/d/1T1…

Not talked about enough with price transparency: these prices are part of negotiations and revealing the outcome of one negotiation changes the bargaining positions for other negotiations.

It is possible that for parts of the market increasing transparency will RAISE prices.

I’m signing. Join us?